TPO and hepatocellular carcinoma: These studies were carried out using H4-11-E-C3 rat hepatoma cells (used because they retain liver-specific functions and respond to IL-6 with upregulation of acute-phase genes, including TPO) and a strong correlation was observed on pathway activation even in the absence of leukocytes, suggesting a direct regulatory mechanism [4].